Searched for
DISHMAN
- Buy Dishman Pharma with a target of Rs 377: Ashwani Gujral"Dishman Pharma is a 'BUY' call with a target of Rs 377 and a stop loss of Rs 355."
- Buy Dishman Pharma with a target of Rs 372: Ashwani Gujral"Dishman Pharma is a 'BUY' call with a target of Rs 372 and a stop loss of Rs 354."
Dishman gets licence from Johnson & Johnson to produce TB drug raw materialDishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...
- Buy Dishman Pharma with a target of Rs 265: Ashwani Gujral'Dishman Pharma Ltd is a 'BUY' call with a target of Rs 265 and a stop loss of Rs 250'
- Buy Dishman Pharma with a target of Rs 232: Ashwani Gujral'Dishman Pharma is a 'BUY' call with a target of Rs 232 and a stop loss of Rs 216'
- Buy Dishman Pharma with a target of Rs 174: Ashwani Gujral'Buy Dishman Pharma with a target of Rs 174 and a stop loss of Rs 160'
- Buy Dishman Pharma at a target of Rs 105: Sandeep Wagle"Buy Dishman Pharma with a stoploss of Rs 90 for target of Rs 105.
- Buy Dishman Pharma with a target of Rs 110: Prakash GabaBuy Dishman Pharma with a target of Rs 110 and a stop loss of Rs 94.
- Buy Dishman Pharma with a target of Rs 95: Prakash GabaBuy Dishman Pharma with a target of Rs 95 and a stop loss of Rs 86: Prakash Gaba.
- Buy Dishman Pharma with a target of Rs 86: Prakash GabaBuy Dishman Pharma with a target of Rs 86 and a stop loss of Rs 78: Prakash Gaba.
- Buy Dishman Pharma with a target of Rs 80: Ashwani GujralBuy Dishman Pharma with a stoploss of Rs 64 for a target of Rs 80: Ashwani Gujral.
- Dishman Group appoints Mark Griffiths as CEODrug firm Dishman Pharmaceuticals and Chemicals today said Mark Griffiths has been appointed as Chief Executive Officer of Dishman Group of...
- Buy Dishman Pharma with a target of 110: Prakash GabaDishman Pharma Ltd is a ‘BUY’ call with a target of Rs 110 and a stop loss of Rs 104.
- Buy Dishman Pharma with a target of 103: Prakash GabaDishman Pharma Ltd is a ‘BUY’ call with a target of Rs 103 and a stop loss of Rs 95.
- Buy Dishman Pharma with a target of 97: Deepak MohoniDishman Pharma Ltd is a ‘BUY’ call with a target of Rs 97 and a stop loss of Rs 92.
- Buy Dishman Pharma with a target of 1081-1089: Rajat BoseDishman Pharma Ltd is a ‘BUY’ call with target of Rs 1081-1089 and a stop loss of Rs 1064.
- Dishman Pharmaceuticals & Chemicals Ltd's net profit up by 155%Dishman Pharmaceuticals & Chemicals Ltd is back in black in the first quarter results for the Financial Year 2012-13 after last year slump.
- Buy Dishman Pharma with a target of 73: Prakash GabaDishman Pharma Ltd is a ‘BUY’ call with a target of Rs 73 and a stop loss of Rs 67.
- Dishman to exit SEZ biz, raise Rs 600 croreDishman Pharma scraps its SEZ project. Will sell its SEZ land near Ahmedabad to off its bank debt.
- Dishman Pharma might take a lot of time in regaining investor confidence: Pankaj Pandey, ICICI DirectFor the past five or six quarters, Dishman Pharma management has not been able to deliver in terms of what they have been setting expectati...
Load More- Buy Dishman Pharma with a target of Rs 265: Ashwani Gujral
